Engelbert Catherine M.
SEC CIK 1796439 · EDGAR
BoughtSold
Most active insiders at RPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coyne Terrance P. | EVP, CFO | — | $38.96M |
| 2 | Hite Christopher | EVP, Vice COB | — | $27.36M |
| 3 | Lloyd George W. | EVP, CLO, Investments | — | $13.81M |
| 4 | Urist Marshall | EVP, Research, Investments | — | $12.07M |
| 5 | Norden Gregory | Dir | — | $161.4K |
| 6 | Engelbert Catherine M. | Dir | — | — |
| 7 | Ho Carole | Dir | — | — |
| 8 | Coric Vlad | Dir | — | — |
| 9 | Bassler Bonnie L | Dir | — | — |
| 10 | Legorreta Pablo G. | CEO, COB, Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-08 16:22 | 2026-06-05 | RPRX | Royalty Pharma plc | Engelbert Catherine M. | Dir | A - Grant | $0.00 | +4,545 | 55.7K | +9% | $0 | |
| 2025-05-15 | 2025-05-13 | RPRX | Royalty Pharma plc | Engelbert Catherine M. | Dir | A - Grant | $0.00 | +7,614 | 51.1K | +17% | $0 | |
| 2024-06-10 | 2024-06-07 | RPRX | Royalty Pharma plc | Engelbert Catherine M. | Dir | A - Grant | $0.00 | +9,293 | 43.5K | +27% | $0 | |
| 2023-08-04 | 2023-04-03 | MCD | McDonald's | Engelbert Catherine M. | Dir | P - Purchase | $281.03 | +38 | 2,079 | +2% | +$10.7K | |
| 2023-06-26 | 2023-06-23 | RPRX | Royalty Pharma plc | Engelbert Catherine M. | Dir | A - Grant | $0.00 | +7,747 | 33.2K | +30% | $0 | |
| 2022-06-24 | 2022-06-24 | RPRX | Royalty Pharma plc | Engelbert Catherine M. | Dir | A - Grant | $0.00 | +6,328 | 25.5K | +33% | $0 | |
| 2022-03-02 | 2022-02-28 | MCD | McDonald's | Engelbert Catherine M. | Dir | P - Purchase | $244.18 | +1,000 | 2,041 | +96% | +$244.2K |
Purchase Sale Sale after option exercise All abbreviations